Christina M Annunziata Selected Research

Cytokines

1/2019	Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use.
1/2017	Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.
1/2016	Monocyte and interferon based therapy for the treatment of ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christina M Annunziata Research Topics

Disease

55	Neoplasms (Cancer) 02/2024 - 10/2006
35	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 11/2007
9	Carcinoma (Carcinomatosis) 10/2022 - 01/2017
6	Tics (Tic) 10/2023 - 02/2015
4	Breast Neoplasms (Breast Cancer) 10/2023 - 02/2010
4	Triple Negative Breast Neoplasms 10/2023 - 10/2017
4	Disease Progression 01/2020 - 03/2016
4	Neutropenia 04/2019 - 05/2013
4	Carcinogenesis 12/2017 - 11/2012
4	Multiple Myeloma 12/2017 - 08/2007
3	Neoplasm Metastasis (Metastasis) 10/2022 - 05/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2020 - 01/2018
3	Thrombocytopenia (Thrombopenia) 04/2019 - 03/2017
3	Ovarian Epithelial Carcinoma 02/2016 - 11/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 01/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 12/2017 - 03/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2017 - 03/2012
2	Fatigue 07/2017 - 05/2013
1	Endometrial Neoplasms (Endometrial Cancer) 10/2023
1	Colorectal Neoplasms (Colorectal Cancer) 03/2023
1	Confusion (Bewilderment) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Aneuploidy (Aneuploid) 01/2022
1	Lactic Acidosis 12/2020

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 02/2023 - 10/2006
9	PlatinumIBA 02/2024 - 01/2014
9	Monoclonal AntibodiesIBA 04/2023 - 02/2013
9	olaparibIBA 01/2020 - 01/2014
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2013
7	Small Interfering RNA (siRNA)IBA 10/2023 - 11/2012
6	Transcription Factors (Transcription Factor)IBA 04/2023 - 05/2010
6	Carboplatin (JM8)FDA LinkGeneric 06/2021 - 06/2014
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 02/2010
5	Immunoglobulin G (IgG)IBA 03/2023 - 01/2017
5	birinapantIBA 02/2023 - 01/2016
5	Bevacizumab (Avastin)FDA Link 01/2023 - 08/2008
4	AntigensIBA 03/2023 - 01/2017
4	CaspasesIBA 02/2023 - 12/2020
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2010
4	Phosphotransferases (Kinase)IBA 10/2020 - 05/2010
4	InterferonsIBA 01/2019 - 01/2016
4	NF-kappa B (NF-kB)IBA 05/2018 - 08/2007
3	EnzymesIBA 10/2023 - 02/2013
3	Polysaccharides (Glycans)IBA 04/2023 - 10/2022
3	Immune Checkpoint InhibitorsIBA 03/2023 - 01/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 11/2007
3	Complement System Proteins (Complement)IBA 06/2022 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 11/2018
3	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 08/2008
3	durvalumabIBA 01/2020 - 07/2017
3	CytokinesIBA 01/2019 - 01/2016
3	Cisplatin (Platino)FDA LinkGeneric 03/2018 - 11/2007
2	TIC10 compoundIBA 10/2023 - 10/2022
2	Hormones (Hormone)IBA 10/2023 - 12/2015
2	LigandsIBA 10/2023 - 04/2019
2	Death Domain ReceptorsIBA 10/2023 - 01/2023
2	Cell-Free Nucleic AcidsIBA 01/2023 - 10/2020
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 02/2013
2	UbiquitinIBA 01/2023 - 12/2017
2	Carcinoembryonic AntigenIBA 06/2022 - 04/2020
2	Disulfiram (Antabuse)FDA Link 01/2022 - 06/2020
2	Interferon-gamma (Interferon, gamma)IBA 01/2019 - 01/2016
2	B7-H1 AntigenIBA 01/2019 - 07/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2010
2	cediranib (AZD2171)IBA 01/2019 - 07/2017
2	Interferon-alpha (Interferon Alfa)IBA 01/2019 - 01/2016
2	Topotecan (Hycamtin)FDA LinkGeneric 03/2018 - 03/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 02/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2017 - 03/2012
2	Bortezomib (Velcade)FDA Link 12/2017 - 03/2012
2	Protein Isoforms (Isoforms)IBA 06/2015 - 11/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2010 - 11/2007
1	KPT-9274IBA 02/2024
1	Proteoglycans (Proteoglycan)IBA 10/2023
1	Uridine Diphosphate Glucose DehydrogenaseIBA 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023
1	MicroRNAs (MicroRNA)IBA 04/2023
1	pembrolizumabIBA 03/2023
1	Histone Deacetylase InhibitorsIBA 02/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	dichlorobis(azomycin)platinum IIIBA 01/2023
1	flotillinsIBA 01/2023
1	Ligases (Synthetase)IBA 01/2023
1	EpitopesIBA 10/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	Cell Adhesion MoleculesIBA 06/2022
1	Peptides (Polypeptides)IBA 06/2022
1	CollagenIBA 06/2022
1	Caspase 8 (Caspase-8)IBA 06/2021
1	Drug CombinationsIBA 12/2020
1	Docetaxel (Taxotere)FDA Link 12/2020
1	Metformin (Glucophage)FDA LinkGeneric 12/2020

Therapy/Procedure

20	Therapeutics 01/2023 - 10/2006
16	Drug Therapy (Chemotherapy) 01/2023 - 04/2008
6	Immunotherapy 01/2023 - 01/2016
2	Radiotherapy 12/2020 - 07/2020
1	Precision Medicine 02/2024